Commentary & News
Archived Headlines
- Obesity biotech BioAge Labs sets terms for $135 million IPO 09/18/24
- Hong Kong-based SPAC YHN Acquisition I prices $60 million IPO 09/18/24
- Tech-focused SPAC Roman DBDR Acquisition II files for a $200 million IPO 09/17/24
- Chinese insurance distributor Yuanbao files for a $50 million US IPO 09/17/24
- Micro-cap cancer biotech Kairos Pharma prices IPO at $4 09/17/24
See more
Music venue and restaurant operator Venu Holding sets terms for $10 million IPO
Venu Holding, which owns and operates music venues and restaurants, announced terms for its IPO on Thursday. The Colorado Springs, CO-based company, which originally filed in August as "Notes Live", plans to raise $10 million by offering 1 million shares at a...read more
SPAC Newbury Street Acquisition II, led by former Turner Sports exec, cuts shares offered 25% ahead of $150 million IPO
Newbury Street Acquisition II, a second blank check company led by the former COO of Turner Sports, lowered the proposed deal size for its upcoming IPO on Thursday. The Boston, MA-based company now plans to raise $150 million by offering 15 million units at $10...read more
Early-stage oil and gas E&P Lafayette Energy increases range to $4 to $5 ahead of $5 million IPO
Lafayette Energy, an oil and gas E&P operating in Utah and Louisiana, raised the proposed deal size for its upcoming IPO on Thursday. The Woods Cross, UT-based company once again plans to raise $5 million by offering 1.2 million shares at a price range of...read more
Respiratory disorder biotech Upstream Bio files for a $100 million IPO
Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. The company's lead candidate is verekitug, a monoclonal...read more